LDLR p.Ala540Ser
c.1618G>T · rs769370816 · VCV251938
ClinGen expert panel — Familial Hypercholesterolemia VCEP
Likely Pathogenic for hypercholesterolemia, familial. Applied ACMG criteria (verbatim):
PM2 PP3 PP4 PM5
Curation rationale (ClinGen, verbatim)
The NM_000527.5(LDLR):c.1618G>T (p.Ala540Ser) variant is classified as Likely pathogenic for Familial Hypercholesterolemia by applying evidence codes PM2, PM5, PP3, PP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: PM2 - variant was not identified in gnomAD (gnomAD v2.1.1), so met. PM5 - 1 other missense variant in the same codon: - NM_000527.5(LDLR):c.1618G>A (p.Ala540Thr) - 2 stars, Pathogenic/Likely pathogenic - Pathogenic by these guidelines so PM5 is met. PP3 - REVEL = 0.821. It is above 0.75, so PP3 is met. PP4 - variant meets PM2 and was identified in: - at least 1 index case with definite FH ((in the paper: "All patients were clinically diagnosed with definite heterozygous hypercholesterolemia by cardiologists and internists using a uniform protocol and internationally accepted criteria [Defesche, 2000].") from PMID 16250003 (Fouchier et al., 2005), The Netherlands. so PP4 is met.
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1495 | likely benign ⚠ discordant with ClinVar |
|---|---|---|
| REVEL | 0.821 | moderately pathogenic-leaning |
| SaProt | LLR -9.57 | tolerated |
| ⇒ REVEL calls this damaging; AlphaMissense and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 11 | GERP 2.5, phastCons 1 |
| Regional constraint | o/e 1.00 | unconstrained · MANE · 42 kb · p 0.91 · regional, not allelic |
| Overall | ||
| CADD | 25.7 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- LDLR
- Protein
- p.Ala540Ser
- Coding
- c.1618G>T
- MANE Select
- NM_000527
- dbSNP
- rs769370816
- Type
- single nucleotide variant
- Location
- chr19:11116125 (GRCh38)
- Gene constraint
- LOEUF 1.091 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 75.81 · 36 PDB
Similar variants
- LDLR p.Ala540Thr Pathogenic ★★★ same residue
- LDLR p.Ala540Val Likely pathogenic ★ same residue
- LDLR p.Ala540del Uncertain significance ★★ same residue
- LDLR c.1186+5G>A Likely pathogenic ★★★ same condition
- LDLR c.1359-1G>A Pathogenic ★★★ same condition
- LDLR c.1359-5C>G Likely pathogenic ★★★ same condition
- LDLR c.1705+2T>C Likely pathogenic ★★★ same condition
- LDLR c.190+4A>T Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ldlr-p-ala540ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown